Enzymatic methylation of arsenic compounds. IX. Liver arsenite methyltransferase and arsenate reductase activities in primates - PubMed (original) (raw)
Comparative Study
. 2001 Nov 30;168(3):213-21.
doi: 10.1016/s0300-483x(01)00481-4.
Affiliations
- PMID: 11684318
- DOI: 10.1016/s0300-483x(01)00481-4
Comparative Study
Enzymatic methylation of arsenic compounds. IX. Liver arsenite methyltransferase and arsenate reductase activities in primates
E Wildfang et al. Toxicology. 2001.
Abstract
Inorganic arsenic is an important environmental toxicant of both natural and anthropogenic sources. It is a human carcinogen for which appropriate animal models of most arsenic-induced cancers are missing. Although methylation of inorganic arsenic has been considered its primary mechanism for detoxification, the results of recent investigations disagree. We have investigated 17 species of non-human primates, including great apes, New and Old World monkeys and prosimians, and have found that thirteen of them lacked hepatic arsenite methyltransferase activity in vitro. Four primate species, three from the Old World genus Macaca, and one of three animals from the New World genus Saimiri, had arsenite methyltransferase activity. That all the tissues examined were viable was demonstrated by their all having arsenate reductase activity. These data suggest that methylation of inorganic arsenic is not a detoxification mechanism for many non-human primates. Thus, alternative methods of detoxifying inorganic arsenic in mammals need to be considered and investigated. In addition, there appears to be a phylogenetic component to having arsenite methyltransferase activity, as evidenced by the result of our study of the Macaca species.
Similar articles
- Enzymatic methylation of arsenic compounds. III. The marmoset and tamarin, but not the rhesus, monkeys are deficient in methyltransferases that methylate inorganic arsenic.
Zakharyan RA, Wildfang E, Aposhian HV. Zakharyan RA, et al. Toxicol Appl Pharmacol. 1996 Sep;140(1):77-84. doi: 10.1006/taap.1996.0199. Toxicol Appl Pharmacol. 1996. PMID: 8806872 - Diversity of inorganic arsenite biotransformation.
Healy SM, Wildfang E, Zakharyan RA, Aposhian HV. Healy SM, et al. Biol Trace Elem Res. 1999 Jun;68(3):249-66. doi: 10.1007/BF02783907. Biol Trace Elem Res. 1999. PMID: 10328340 Review. - Enzymatic methylation of arsenic compounds. VI. Characterization of hamster liver arsenite and methylarsonic acid methyltransferase activities in vitro.
Wildfang E, Zakharyan RA, Aposhian HV. Wildfang E, et al. Toxicol Appl Pharmacol. 1998 Oct;152(2):366-75. doi: 10.1006/taap.1998.8409. Toxicol Appl Pharmacol. 1998. PMID: 9853005 - Enzymatic reduction of arsenic compounds in mammalian systems: reduction of arsenate to arsenite by human liver arsenate reductase.
Radabaugh TR, Aposhian HV. Radabaugh TR, et al. Chem Res Toxicol. 2000 Jan;13(1):26-30. doi: 10.1021/tx990115k. Chem Res Toxicol. 2000. PMID: 10649963 - Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity.
Aposhian HV. Aposhian HV. Annu Rev Pharmacol Toxicol. 1997;37:397-419. doi: 10.1146/annurev.pharmtox.37.1.397. Annu Rev Pharmacol Toxicol. 1997. PMID: 9131259 Review.
Cited by
- Mechanisms Associated with Cognitive and Behavioral Impairment Induced by Arsenic Exposure.
Vázquez Cervantes GI, González Esquivel DF, Ramírez Ortega D, Blanco Ayala T, Ramos Chávez LA, López-López HE, Salazar A, Flores I, Pineda B, Gómez-Manzo S, Pérez de la Cruz V. Vázquez Cervantes GI, et al. Cells. 2023 Oct 28;12(21):2537. doi: 10.3390/cells12212537. Cells. 2023. PMID: 37947615 Free PMC article. Review. - Arsenic: Various species with different effects on cytochrome P450 regulation in humans.
El-Ghiaty MA, El-Kadi AOS. El-Ghiaty MA, et al. EXCLI J. 2021 Jul 12;20:1184-1242. doi: 10.17179/excli2021-3890. eCollection 2021. EXCLI J. 2021. PMID: 34512225 Free PMC article. Review. - Toxicity Screening of Single Dose of Inorganic and Organic Arsenics on Hematological and Serum Biochemical Parameters in Male Cynomolgus Monkeys.
Kim CY, Han KH, Heo JD, Han E, Yum Y, Lee JY, Park K, Im R, Choi SJ, Park JD. Kim CY, et al. Toxicol Res. 2008 Sep;24(3):219-225. doi: 10.5487/TR.2008.24.3.219. Epub 2008 Sep 1. Toxicol Res. 2008. PMID: 32038799 Free PMC article. - Methylated Organic Metabolites of Arsenic and their Cardiovascular Toxicities.
Bae ON, Lim KM, Noh JY, Kim KY, Lim EK, Chung JH. Bae ON, et al. Toxicol Res. 2008 Sep;24(3):161-167. doi: 10.5487/TR.2008.24.3.161. Epub 2008 Sep 1. Toxicol Res. 2008. PMID: 32038790 Free PMC article. Review. - Early origins of adult disease: approaches for investigating the programmable epigenome in humans, nonhuman primates, and rodents.
Ganu RS, Harris RA, Collins K, Aagaard KM. Ganu RS, et al. ILAR J. 2012;53(3-4):306-21. doi: 10.1093/ilar.53.3-4.306. ILAR J. 2012. PMID: 23744969 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- ES-04940/ES/NIEHS NIH HHS/United States
- P30-ES-06694/ES/NIEHS NIH HHS/United States
- RR00163/RR/NCRR NIH HHS/United States
- RR00165/RR/NCRR NIH HHS/United States
- RR00166/RR/NCRR NIH HHS/United States
- RR00168/RR/NCRR NIH HHS/United States
- RR01254/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources